Pravachol, Pravastatin

Pravachol, Pravastatin Newswire

Comprehensive Real-Time News Feed for Pravachol, Pravastatin (generic).

Results 1 - 20 of 55 in Pravachol, Pravastatin (generic)

  1. Urine test could lead to better treatment of bladder cancerRead the original story

    Friday | Science Daily

    A simple urine test could help to guide clinicians in the treatment of bladder cancer patients, researchers believe. Being able to reliably identify those patients with the most aggressive cancers early via urine tests, and expediting aggressive therapeutic strategies, may significantly improve outcomes, they say.

    Comment?

  2. New approach to assessing effectiveness of anti-cancer drugsRead the original story

    Friday | Science Daily

    Scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukemia stem cells. The approach potentially allows doctors to screen patients and personalize their treatment.

    Comment?

  3. Synthetic biology breakthrough leads to cheaper statin productionRead the original story

    Friday | Science Daily

    Researchers have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production. University of Manchester researchers, together with industrial partner DSM, have developed a single-step fermentative method for the production of leading cholesterol-lowering drug, pravastatin, which will facilitate industrial-scale statin drug production.

    Comment?

  4. Cardiac and respiratory function supported by abdominal muscles in muscular dystrophyRead the original story

    Friday | Science Daily

    The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy can also lead to decreased function of specific muscles involved in respiration causing breathing difficulties as well as leading to cardiac problems.

    Comment?

  5. Single-step fermentative method for the production of cholesterol-lowering drug pravastatinRead the original story w/Photo

    Friday | PhysOrg Weblog

    In a study published in Proceedings of the National Academy of Sciences , the researchers have devised a single-step fermentative method for the industrial production of the active drug pravastatin that previously involved a costly dual-step fermentation and biotransformation process. Reprogramming the antibiotics-producing fungus Penicillium chrysogenum, with discovery and engineering of a cytochrome P450 enzyme involved in the hydroxylation of the precursor compactin, enabled high level fermentation of the correct form of pravastatin to facilitate efficient industrial-scale statin drug production.

    Comment?

  6. DRL faces US probe on pricingRead the original story

    Wednesday Feb 25 | The Telegraph

    Hyderabad, Feb. 25 : The attorney generals of Texas and California have separately sought information on the pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing of the drug maker with the US Securities and Exchange Commission . The development comes after two members of United States Congress wrote to the company, requesting information and expressing "concern" over the "escalating prices" of two products - divalproex sodium ER and pravastatin sodium - marketed by it in the US.

    Comment?

  7. AGs of Texas, California probe DRL's drug pricing mechanismRead the original story

    Tuesday Feb 24 | Mydigitalfc.com

    Attorney Generals of Texas and California have separately sought information on pricing of some drugs sold by Dr Reddy's Laboratories in the US, according to the latest filing for the drug maker with SEC. The development comes after two members of the United States Congress wrote to the company requesting information and expressing "concern" over the "escalating prices" of two products -- divalproex sodium ER and pravastatin sodium -- marketed by it in the United States.

    Comment?

  8. Danqi Pill regulates lipid metabolism disorder induced by myocardial...Read the original story

    Saturday Feb 21 | BioMed Central

    Background Danqi Pill , which contains Chinese herbs Salvia miltiorrhiza Bunge and Panax notoginseng, is widely used in the treatment of myocardial ischemia in China. Its regulatory effects on MI-associated lipid metabolism disorders haven't been comprehensively studied so far.

    Comment?

  9. Proven: People Don't Take Medicare They Can't AffordRead the original story w/Photo

    Monday Feb 9 | Forbes.com

    I am a physician and behavioral scientist at Duke University. My research and writing explores the quirks in human nature that influence our lives - the mixture of rational and irrational forces that affect our health, our happiness and the way our society functions.

    Comment?

  10. Proven: People Don't Take Medicare They Can't AffordRead the original story w/Photo

    Monday Feb 9 | Forbes.com

    I am a physician and behavioral scientist at Duke University. My research and writing explores the quirks in human nature that influence our lives - the mixture of rational and irrational forces that affect our health, our happiness and the way our society functions.

    Comment?

  11. Is your cholesterol really too high?Read the original story w/Photo

    Jan 20, 2015 | Inside Bay Area

    There is an International Network of Cholesterol Skeptics - a group of scientists, physicians, other academicians and science writers from various countries - who offer this food for thought.

    Comment?

  12. Clarithromycin-Statin Mix Can Cause Severe Adverse EventsRead the original story

    Jan 21, 2015 | US Pharmacist

    The combination of clarithromycin with certain statins increases the risk of adverse events, which in older patients may necessitate hospitalization. Researchers at Western University examined data on more than 104,000 patients aged 66 years who took rosuvastatin, pravastatin, or fluvastatin and also had a prescription for clarithromycin or azithromycin.

    Comment?

  13. Glenmark Generics Limited - Strategic SWOT Analysis Review - New Study ReleasedRead the original story

    Jan 17, 2015 | PR-inside.com

    Glenmark Generics Limited is a pharmaceutical company. The company develops, manufactures, markets and distributes generic finished dosage forms and active pharmaceutical ingredients.

    Comment?

  14. Severe hepatic injury associated with different statinsRead the original story

    Jan 13, 2015 | GastroHep.com

    A study in the most recent issue of the Journal of Gastroenterology & Hepatology investigates severe hepatic injury associated with different statins in patients with chronic liver disease. In this study, Dr Jou-Wei Lin and colleagues from Taiwan estimated the risk of severe hepatic injury associated with different statins in patients with chronic liver disease.

    Comment?

  15. Low risk of statin-linked hepatic injury in liver diseaseRead the original story w/Photo

    Jan 7, 2015 | PhysOrg Weblog

    For patients with chronic liver disease, statin initiation is associated with low overall incidence of hospitalization due to severe hepatic injury, according to a study published in the January issue of the Journal of Gastroenterology and Hepatology . Chia-Hsuin Chang, M.D., Ph.D., from the National Taiwan University in Dou-Liou City, and colleagues conducted a nationwide population-based cohort study involving 37,929 subjects with chronic liver disease who started statin therapy .

    Comment?

  16. Use of cholesterol-lowering meds on the riseRead the original story w/Photo

    Dec 24, 2014 | Fox News

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  17. Mixing clarithromycin with statins could lead to hospitalizationRead the original story w/Photo

    Dec 23, 2014 | Medical News Today

    The antibiotic clarithromycin and cholesterol-lowering statins are some of the most widely prescribed drugs in the world. New research, however, has found that certain combinations of the two could increase the risk of adverse events and, in certain cases, could lead to hospitalization.

    Comment?

  18. Certain Antibiotic/Statin Combos May Be Unsafe MixRead the original story w/Photo

    Dec 22, 2014 | MedlinePlus

    Seniors who take the antibiotic Biaxin along with certain types of cholesterol-lowering statins are at risk for drug interaction side effects that can lead to hospitalization or even death, a new study suggests. "Physicians need to be made aware of this newly described dangerous interaction and consider alternative antibiotics to prevent toxicity that could be life-threatening," said expert Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y. He was not involved in the new study, which appears in the Dec. 22 issue of the Canadian Medical Association Journal .

    Comment?

  19. Use of Cholesterol-Lowering Meds on the RiseRead the original story w/Photo

    Dec 22, 2014 | LiveScience

    The percentage of Americans taking medication to control their cholesterol has risen by a third over the past decade, a new study finds. In 2012, the percentage of people ages 40 and over who said they had used a cholesterol-lowering medication in the past month was 28 percent, up from 20 percent in 2003, according to the report from the Centers for Disease Control and Prevention.

    Comment?

  20. Clarithromycin Plus Certain Statins Associated with Hospitalization Risk in Older AdultsRead the original story

    Dec 22, 2014 | Journal Watch

    Using Canadian healthcare databases, researchers examined records of 100,000 patients aged 66 and older who were taking statins not metabolized by CYP3A4 and who also received a prescription for either clarithromycin or azithromycin. Clarithromycin inhibits OATP1B1 and OATP1B3, but azithromycin does not.

    Comment?